1	The	_	DT	_	_	3	NMOD	_	_
2	present	_	JJ	_	_	3	NMOD	_	_
3	report	_	NN	_	_	4	VMOD	_	_
4	showed	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	null	_	NN	_	_	7	NMOD	_	_
7	mutations	_	NNS	_	_	13	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	mouse	_	NN	_	_	12	NMOD	_	_
11	Sharpin	_	NN	_	_	12	NMOD	_	_
12	gene	_	NN	_	_	8	PMOD	_	_
13	did	_	VBD	_	_	5	SUB	_	_
14	not	_	RB	_	_	13	VMOD	_	_
15	affect	_	VB	_	_	13	VC	_	_
16	the	_	DT	_	_	18	NMOD	_	_
17	steady-state	_	JJ	_	_	18	NMOD	_	_
18	distribution	_	NN	_	_	15	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	splenic	_	JJ	_	_	22	NMOD	_	_
21	DC	_	NN	_	_	22	NMOD	_	_
22	subsets	_	NNS	_	_	19	PMOD	_	_
23	nor	_	CC	_	_	18	COORD	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	development	_	NN	_	_	23	CONJ	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	phenotype	_	NN	_	_	26	CONJ	_	_
28	of	_	IN	_	_	25	NMOD	_	_
29	BMDC	_	NN	_	_	28	PMOD	_	_
30	.	_	.	_	_	4	P	_	_
		
1	However	_	RB	_	_	7	VMOD	_	_
2	,	_	,	_	_	7	P	_	_
3	loss	_	NN	_	_	7	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	SHARPIN	_	NN	_	_	4	PMOD	_	_
6	significantly	_	RB	_	_	7	VMOD	_	_
7	diminished	_	VBD	_	_	0	ROOT	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	capacity	_	NN	_	_	7	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	BMDC	_	NN	_	_	10	PMOD	_	_
12	to	_	TO	_	_	9	NMOD	_	_
13	secrete	_	VB	_	_	12	IM	_	_
14	inflammatory	_	JJ	_	_	15	NMOD	_	_
15	cytokines	_	NNS	_	_	13	VMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	nitric	_	JJ	_	_	18	NMOD	_	_
18	oxide	_	NN	_	_	16	CONJ	_	_
19	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	attenuated	_	VBN	_	_	4	NMOD	_	_
3	cytokine	_	NN	_	_	4	NMOD	_	_
4	production	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	not	_	RB	_	_	5	VMOD	_	_
7	due	_	JJ	_	_	5	VMOD	_	_
8	to	_	TO	_	_	7	AMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	presence	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	anti-inflammatory	_	JJ	_	_	13	NMOD	_	_
13	inhibitors	_	NNS	_	_	11	PMOD	_	_
14	,	_	,	_	_	5	P	_	_
15	and	_	CC	_	_	5	COORD	_	_
16	can	_	MD	_	_	15	CONJ	_	_
17	be	_	VB	_	_	16	VC	_	_
18	largely	_	RB	_	_	17	VMOD	_	_
19	explained	_	VBN	_	_	17	VC	_	_
20	by	_	IN	_	_	19	VMOD	_	_
21	selective	_	JJ	_	_	22	NMOD	_	_
22	inactivation	_	NN	_	_	20	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	NF-kappaB	_	NN	_	_	25	NMOD	_	_
25	signaling	_	NN	_	_	23	PMOD	_	_
26	.	_	.	_	_	5	P	_	_
		
1	Stimulated	_	VBN	_	_	3	NMOD	_	_
2	cpdm	_	NN	_	_	3	NMOD	_	_
3	BMDC	_	NNS	_	_	4	VMOD	_	_
4	exhibited	_	VBD	_	_	0	ROOT	_	_
5	Th2-biased	_	JJ	_	_	8	NMOD	_	_
6	T	_	NN	_	_	8	NMOD	_	_
7	cell-polarizing	_	NN	_	_	8	NMOD	_	_
8	capabilities	_	NNS	_	_	4	VMOD	_	_
9	,	_	,	_	_	4	P	_	_
10	consistent	_	JJ	_	_	4	VMOD	_	_
11	with	_	IN	_	_	10	AMOD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	Th2	_	NN	_	_	15	NMOD	_	_
14	cytokine-dominant	_	JJ	_	_	15	NMOD	_	_
15	phenotype	_	NN	_	_	11	PMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	cpdm	_	NN	_	_	18	NMOD	_	_
18	mice	_	NNS	_	_	16	PMOD	_	_
19	.	_	.	_	_	4	P	_	_
		
1	Together	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	these	_	DT	_	_	4	NMOD	_	_
4	results	_	NNS	_	_	5	VMOD	_	_
5	indicate	_	VBP	_	_	0	ROOT	_	_
6	an	_	DT	_	_	8	NMOD	_	_
7	indispensible	_	JJ	_	_	8	NMOD	_	_
8	role	_	NN	_	_	5	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	SHARPIN	_	NN	_	_	9	PMOD	_	_
11	in	_	IN	_	_	8	NMOD	_	_
12	regulating	_	VBG	_	_	11	PMOD	_	_
13	DC	_	NN	_	_	15	NMOD	_	_
14	immunological	_	JJ	_	_	15	NMOD	_	_
15	functions	_	NNS	_	_	12	VMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	disruption	_	NN	_	_	20	VMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	which	_	WDT	_	_	18	PMOD	_	_
20	may	_	MD	_	_	15	NMOD	_	_
21	contribute	_	VB	_	_	20	VC	_	_
22	to	_	TO	_	_	21	VMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	development	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	immune	_	JJ	_	_	27	NMOD	_	_
27	diseases	_	NNS	_	_	25	PMOD	_	_
28	.	_	.	_	_	5	P	_	_
		
1	Since	_	IN	_	_	23	VMOD	_	_
2	WT	_	NN	_	_	5	NMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	cpdm	_	NN	_	_	3	CONJ	_	_
5	mice	_	NNS	_	_	6	VMOD	_	_
6	are	_	VBP	_	_	1	SUB	_	_
7	both	_	DT	_	_	9	NMOD	_	_
8	specific	_	JJ	_	_	9	NMOD	_	_
9	pathogen-free	_	JJ	_	_	6	VMOD	_	_
10	,	_	,	_	_	23	P	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	nature	_	NN	_	_	23	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	trigger	_	NN	_	_	13	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	19	NMOD	_	_
18	severe	_	JJ	_	_	19	NMOD	_	_
19	inflammation	_	NN	_	_	16	PMOD	_	_
20	in	_	IN	_	_	19	NMOD	_	_
21	cpdm	_	NN	_	_	22	NMOD	_	_
22	mice	_	NNS	_	_	20	PMOD	_	_
23	is	_	VBZ	_	_	0	ROOT	_	_
24	not	_	RB	_	_	23	VMOD	_	_
25	obvious	_	JJ	_	_	23	VMOD	_	_
26	.	_	.	_	_	23	P	_	_
		
1	One	_	CD	_	_	4	NMOD	_	_
2	such	_	JJ	_	_	4	NMOD	_	_
3	initiating	_	VBG	_	_	4	NMOD	_	_
4	factor	_	NN	_	_	5	VMOD	_	_
5	could	_	MD	_	_	0	ROOT	_	_
6	be	_	VB	_	_	5	VC	_	_
7	endogenous	_	JJ	_	_	11	NMOD	_	_
8	apoptotic	_	JJ	_	_	11	NMOD	_	_
9	and/or	_	CC	_	_	8	COORD	_	_
10	necrotic	_	JJ	_	_	9	CONJ	_	_
11	cells	_	NNS	_	_	6	VMOD	_	_
12	that	_	WDT	_	_	13	VMOD	_	_
13	can	_	MD	_	_	11	NMOD	_	_
14	release	_	VB	_	_	13	VC	_	_
15	danger-associated	_	JJ	_	_	17	NMOD	_	_
16	molecular	_	JJ	_	_	17	NMOD	_	_
17	patterns	_	NNS	_	_	14	VMOD	_	_
18	(	_	(	_	_	19	P	_	_
19	DAMPs	_	NNS	_	_	17	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	to	_	TO	_	_	17	NMOD	_	_
22	launch	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	14	COORD	_	_
24	amplify	_	VB	_	_	23	CONJ	_	_
25	an	_	DT	_	_	27	NMOD	_	_
26	inflammatory	_	JJ	_	_	27	NMOD	_	_
27	response	_	NN	_	_	24	VMOD	_	_
28	[	_	(	_	_	27	P	_	_
29	32	_	CD	_	_	27	NMOD	_	_
30	]	_	)	_	_	27	P	_	_
31	.	_	.	_	_	5	P	_	_
		
1	Such	_	JJ	_	_	5	NMOD	_	_
2	'	_	``	_	_	5	P	_	_
3	sterile	_	JJ	_	_	5	NMOD	_	_
4	'	_	''	_	_	5	P	_	_
5	inflammation	_	NN	_	_	6	VMOD	_	_
6	could	_	MD	_	_	0	ROOT	_	_
7	be	_	VB	_	_	6	VC	_	_
8	initiated	_	VBN	_	_	7	VC	_	_
9	and	_	CC	_	_	6	COORD	_	_
10	take	_	VB	_	_	9	CONJ	_	_
11	place	_	NN	_	_	10	VMOD	_	_
12	in	_	IN	_	_	10	VMOD	_	_
13	all	_	DT	_	_	14	NMOD	_	_
14	organs	_	NNS	_	_	12	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	tissues	_	NNS	_	_	15	CONJ	_	_
17	affected	_	VBN	_	_	14	APPO	_	_
18	in	_	IN	_	_	17	VMOD	_	_
19	cpdm	_	NN	_	_	20	NMOD	_	_
20	mice	_	NNS	_	_	18	PMOD	_	_
21	,	_	,	_	_	6	P	_	_
22	thus	_	RB	_	_	23	VMOD	_	_
23	causing	_	VBG	_	_	6	VMOD	_	_
24	multi-organ	_	JJ	_	_	26	NMOD	_	_
25	inflammatory	_	JJ	_	_	26	NMOD	_	_
26	disorders	_	NNS	_	_	23	VMOD	_	_
27	.	_	.	_	_	6	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	hypothesis	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	supported	_	VBN	_	_	3	VC	_	_
5	by	_	IN	_	_	4	VMOD	_	_
6	several	_	JJ	_	_	8	NMOD	_	_
7	recent	_	JJ	_	_	8	NMOD	_	_
8	studies	_	NNS	_	_	5	PMOD	_	_
9	.	_	.	_	_	3	P	_	_
		
1	Fibroblasts	_	NNS	_	_	5	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	cpdm	_	NN	_	_	4	NMOD	_	_
4	mice	_	NNS	_	_	2	PMOD	_	_
5	are	_	VBP	_	_	0	ROOT	_	_
6	highly	_	RB	_	_	7	AMOD	_	_
7	sensitive	_	JJ	_	_	5	VMOD	_	_
8	to	_	TO	_	_	7	AMOD	_	_
9	TNFalpha-induced	_	JJ	_	_	11	NMOD	_	_
10	cell	_	NN	_	_	11	NMOD	_	_
11	death	_	NN	_	_	8	PMOD	_	_
12	and	_	CC	_	_	5	COORD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	cpdm	_	NN	_	_	15	NMOD	_	_
15	phenotype	_	NN	_	_	16	VMOD	_	_
16	can	_	MD	_	_	12	CONJ	_	_
17	be	_	VB	_	_	16	VC	_	_
18	partially	_	RB	_	_	17	VMOD	_	_
19	rescued	_	VBN	_	_	17	VC	_	_
20	by	_	IN	_	_	19	VMOD	_	_
21	deletion	_	NN	_	_	20	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	TNF	_	NN	_	_	22	PMOD	_	_
24	[	_	(	_	_	23	P	_	_
25	7	_	CD	_	_	23	NMOD	_	_
26	]	_	)	_	_	23	P	_	_
27	,	_	,	_	_	23	P	_	_
28	[	_	(	_	_	29	P	_	_
29	8	_	CD	_	_	23	NMOD	_	_
30	]	_	)	_	_	29	P	_	_
31	,	_	,	_	_	19	P	_	_
32	suggesting	_	VBG	_	_	19	VMOD	_	_
33	that	_	IN	_	_	32	VMOD	_	_
34	deficiency	_	NN	_	_	37	VMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	SHARPIN	_	NN	_	_	35	PMOD	_	_
37	compromises	_	VBZ	_	_	33	SUB	_	_
38	the	_	DT	_	_	40	NMOD	_	_
39	anti-apoptotic	_	JJ	_	_	40	NMOD	_	_
40	mechanisms	_	NNS	_	_	37	VMOD	_	_
41	in	_	IN	_	_	40	NMOD	_	_
42	cpdm	_	NN	_	_	43	NMOD	_	_
43	mice	_	NNS	_	_	41	PMOD	_	_
44	resulting	_	VBG	_	_	43	APPO	_	_
45	in	_	IN	_	_	44	VMOD	_	_
46	cell	_	NN	_	_	49	NMOD	_	_
47	death-induced	_	JJ	_	_	49	NMOD	_	_
48	inflammatory	_	JJ	_	_	49	NMOD	_	_
49	disease	_	NN	_	_	45	PMOD	_	_
50	.	_	.	_	_	5	P	_	_
		
1	Apoptosis	_	NN	_	_	4	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	keratinocytes	_	NNS	_	_	2	PMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	a	_	DT	_	_	7	NMOD	_	_
6	prominent	_	JJ	_	_	7	NMOD	_	_
7	feature	_	NN	_	_	4	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	skin	_	NN	_	_	11	NMOD	_	_
11	lesions	_	NNS	_	_	8	PMOD	_	_
12	in	_	IN	_	_	11	NMOD	_	_
13	cpdm	_	NN	_	_	14	NMOD	_	_
14	mice	_	NNS	_	_	12	PMOD	_	_
15	[	_	(	_	_	16	P	_	_
16	33	_	CD	_	_	4	PRN	_	_
17	]	_	)	_	_	16	P	_	_
18	and	_	CC	_	_	4	COORD	_	_
19	this	_	DT	_	_	20	VMOD	_	_
20	is	_	VBZ	_	_	18	CONJ	_	_
21	mediated	_	VBN	_	_	20	VC	_	_
22	by	_	IN	_	_	21	VMOD	_	_
23	caspase-dependent	_	JJ	_	_	25	NMOD	_	_
24	mitochondrial	_	JJ	_	_	25	NMOD	_	_
25	pathways	_	NNS	_	_	22	PMOD	_	_
26	[	_	(	_	_	27	P	_	_
27	34	_	NN	_	_	25	PRN	_	_
28	]	_	)	_	_	27	P	_	_
29	.	_	.	_	_	4	P	_	_
		
1	These	_	DT	_	_	6	NMOD	_	_
2	induced	_	JJ	_	_	6	NMOD	_	_
3	and/or	_	CC	_	_	2	COORD	_	_
4	intrinsic	_	JJ	_	_	3	CONJ	_	_
5	apoptotic	_	JJ	_	_	6	NMOD	_	_
6	cells	_	NNS	_	_	7	VMOD	_	_
7	can	_	MD	_	_	0	ROOT	_	_
8	release	_	VB	_	_	7	VC	_	_
9	various	_	JJ	_	_	10	NMOD	_	_
10	types	_	NNS	_	_	8	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	DAMPs	_	NN	_	_	11	PMOD	_	_
13	that	_	WDT	_	_	14	VMOD	_	_
14	exert	_	VBP	_	_	10	NMOD	_	_
15	their	_	PRP$	_	_	17	NMOD	_	_
16	pro-inflammatory	_	JJ	_	_	17	NMOD	_	_
17	properties	_	NNS	_	_	14	VMOD	_	_
18	by	_	IN	_	_	14	VMOD	_	_
19	activating	_	VBG	_	_	18	PMOD	_	_
20	DC	_	NNS	_	_	19	VMOD	_	_
21	through	_	IN	_	_	19	VMOD	_	_
22	pattern	_	NN	_	_	24	NMOD	_	_
23	recognition	_	NN	_	_	24	NMOD	_	_
24	receptors	_	NNS	_	_	21	PMOD	_	_
25	[	_	(	_	_	26	P	_	_
26	32	_	CD	_	_	24	PRN	_	_
27	]	_	)	_	_	26	P	_	_
28	,	_	,	_	_	24	P	_	_
29	[	_	(	_	_	30	P	_	_
30	35	_	CD	_	_	24	APPO	_	_
31	]	_	)	_	_	30	P	_	_
32	,	_	,	_	_	24	P	_	_
33	such	_	JJ	_	_	34	DEP	_	_
34	as	_	IN	_	_	24	NMOD	_	_
35	HMGB1	_	NN	_	_	34	PMOD	_	_
36	recognized	_	VBN	_	_	35	APPO	_	_
37	by	_	IN	_	_	36	VMOD	_	_
38	TLR2/4	_	NN	_	_	37	PMOD	_	_
39	[	_	(	_	_	38	P	_	_
40	36	_	CD	_	_	38	NMOD	_	_
41	]	_	)	_	_	38	P	_	_
42	,	_	,	_	_	38	P	_	_
43	[	_	(	_	_	44	P	_	_
44	37	_	CD	_	_	38	APPO	_	_
45	]	_	)	_	_	44	P	_	_
46	.	_	.	_	_	7	P	_	_
		
1	Consistent	_	JJ	_	_	15	VMOD	_	_
2	with	_	IN	_	_	1	AMOD	_	_
3	the	_	DT	_	_	7	NMOD	_	_
4	impaired	_	JJ	_	_	7	NMOD	_	_
5	Th1	_	NN	_	_	7	NMOD	_	_
6	immune	_	JJ	_	_	7	NMOD	_	_
7	response	_	NN	_	_	2	PMOD	_	_
8	in	_	IN	_	_	7	NMOD	_	_
9	cpdm	_	NN	_	_	10	NMOD	_	_
10	mice	_	NNS	_	_	8	PMOD	_	_
11	[	_	(	_	_	7	P	_	_
12	5	_	CD	_	_	7	NMOD	_	_
13	]	_	)	_	_	7	P	_	_
14	,	_	,	_	_	15	P	_	_
15	stimulated	_	VBD	_	_	0	ROOT	_	_
16	BMDC	_	NN	_	_	20	NMOD	_	_
17	weakly	_	RB	_	_	18	AMOD	_	_
18	polarized	_	VBN	_	_	20	NMOD	_	_
19	Th1	_	NN	_	_	20	NMOD	_	_
20	differentiation	_	NN	_	_	15	VMOD	_	_
21	,	_	,	_	_	15	P	_	_
22	but	_	CC	_	_	15	COORD	_	_
23	strongly	_	RB	_	_	24	VMOD	_	_
24	supported	_	VBD	_	_	22	CONJ	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	development	_	NN	_	_	24	VMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	Th2	_	NN	_	_	30	NMOD	_	_
29	effector	_	NN	_	_	30	NMOD	_	_
30	cells	_	NNS	_	_	27	PMOD	_	_
31	.	_	.	_	_	15	P	_	_
		
1	Combined	_	JJ	_	_	20	VMOD	_	_
2	with	_	IN	_	_	1	AMOD	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	dramatic	_	JJ	_	_	5	NMOD	_	_
5	effect	_	NN	_	_	2	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	IL12	_	NN	_	_	8	NMOD	_	_
8	treatment	_	NN	_	_	6	PMOD	_	_
9	on	_	IN	_	_	5	NMOD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	phenotype	_	NN	_	_	9	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	these	_	DT	_	_	14	NMOD	_	_
14	mice	_	NNS	_	_	12	PMOD	_	_
15	[	_	(	_	_	5	P	_	_
16	5	_	CD	_	_	5	NMOD	_	_
17	]	_	)	_	_	5	P	_	_
18	,	_	,	_	_	20	P	_	_
19	this	_	DT	_	_	20	VMOD	_	_
20	suggests	_	VBZ	_	_	0	ROOT	_	_
21	that	_	IN	_	_	20	VMOD	_	_
22	the	_	DT	_	_	25	NMOD	_	_
23	Th2-biased	_	JJ	_	_	25	NMOD	_	_
24	systemic	_	JJ	_	_	25	NMOD	_	_
25	inflammation	_	NN	_	_	29	VMOD	_	_
26	in	_	IN	_	_	25	NMOD	_	_
27	cpdm	_	NN	_	_	28	NMOD	_	_
28	mice	_	NNS	_	_	26	PMOD	_	_
29	is	_	VBZ	_	_	21	SUB	_	_
30	caused	_	VBN	_	_	29	VC	_	_
31	by	_	IN	_	_	30	VMOD	_	_
32	reduced	_	VBN	_	_	34	NMOD	_	_
33	IL12P70	_	NN	_	_	34	NMOD	_	_
34	production	_	NN	_	_	31	PMOD	_	_
35	from	_	IN	_	_	34	NMOD	_	_
36	DC	_	NNS	_	_	35	PMOD	_	_
37	.	_	.	_	_	20	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	importance	_	NN	_	_	14	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	IL12P70	_	NN	_	_	3	PMOD	_	_
5	in	_	IN	_	_	2	NMOD	_	_
6	regulating	_	VBG	_	_	5	PMOD	_	_
7	Th1	_	NN	_	_	11	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	Th2	_	NN	_	_	8	CONJ	_	_
10	immune	_	JJ	_	_	11	NMOD	_	_
11	responses	_	NNS	_	_	6	VMOD	_	_
12	in	_	IN	_	_	11	NMOD	_	_
13	mice	_	NNS	_	_	12	PMOD	_	_
14	was	_	VBD	_	_	0	ROOT	_	_
15	clearly	_	RB	_	_	14	VMOD	_	_
16	demonstrated	_	VBN	_	_	14	VC	_	_
17	in	_	IN	_	_	16	VMOD	_	_
18	IL12P35-	_	JJ	_	_	21	NMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	IL12P40-deficient	_	JJ	_	_	19	CONJ	_	_
21	mice	_	NNS	_	_	17	PMOD	_	_
22	[	_	(	_	_	23	P	_	_
23	38	_	CD	_	_	21	PRN	_	_
24	]	_	)	_	_	23	P	_	_
25	,	_	,	_	_	21	P	_	_
26	[	_	(	_	_	27	P	_	_
27	39	_	CD	_	_	21	NMOD	_	_
28	]	_	)	_	_	27	P	_	_
29	and	_	CC	_	_	17	COORD	_	_
30	through	_	IN	_	_	29	CONJ	_	_
31	clinical	_	JJ	_	_	32	NMOD	_	_
32	studies	_	NNS	_	_	30	PMOD	_	_
33	in	_	IN	_	_	32	NMOD	_	_
34	human	_	JJ	_	_	35	NMOD	_	_
35	patients	_	NNS	_	_	33	PMOD	_	_
36	[	_	(	_	_	39	P	_	_
37	40	_	CD	_	_	39	AMOD	_	_
38	]	_	)	_	_	39	P	_	_
39	-[42]	_	JJ	_	_	35	APPO	_	_
40	.	_	.	_	_	14	P	_	_
		
1	NF-kappaB	_	NN	_	_	8	VMOD	_	_
2	,	_	,	_	_	1	P	_	_
3	TBK/IRF3	_	NN	_	_	1	COORD	_	_
4	,	_	,	_	_	3	P	_	_
5	and	_	CC	_	_	3	COORD	_	_
6	MAPK	_	NN	_	_	7	NMOD	_	_
7	signaling	_	NN	_	_	5	CONJ	_	_
8	are	_	VBP	_	_	0	ROOT	_	_
9	important	_	JJ	_	_	10	NMOD	_	_
10	pathways	_	NNS	_	_	8	VMOD	_	_
11	activated	_	VBN	_	_	10	APPO	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	LPS	_	NN	_	_	12	PMOD	_	_
14	or	_	CC	_	_	13	COORD	_	_
15	poly	_	NN	_	_	16	NMOD	_	_
16	I:C	_	NN	_	_	14	CONJ	_	_
17	and	_	CC	_	_	8	COORD	_	_
18	disruption	_	NN	_	_	22	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	either	_	DT	_	_	21	NMOD	_	_
21	pathway	_	NN	_	_	19	PMOD	_	_
22	may	_	MD	_	_	17	CONJ	_	_
23	lead	_	VB	_	_	22	VC	_	_
24	to	_	TO	_	_	23	VMOD	_	_
25	decreased	_	VBN	_	_	27	NMOD	_	_
26	cytokine	_	NN	_	_	27	NMOD	_	_
27	expression	_	NN	_	_	24	PMOD	_	_
28	.	_	.	_	_	8	P	_	_
		
1	NF-kappaB	_	NN	_	_	2	NMOD	_	_
2	activation	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	selectively	_	RB	_	_	5	VMOD	_	_
5	inhibited	_	VBN	_	_	3	VC	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	LPS	_	NN	_	_	11	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	poly	_	NN	_	_	10	NMOD	_	_
10	I:C	_	NN	_	_	8	CONJ	_	_
11	stimulated	_	VBD	_	_	6	SUB	_	_
12	cpdm	_	NN	_	_	13	NMOD	_	_
13	BMDC	_	NN	_	_	11	VMOD	_	_
14	compared	_	VBN	_	_	11	VMOD	_	_
15	to	_	TO	_	_	14	PMOD	_	_
16	wild	_	JJ	_	_	17	NMOD	_	_
17	type	_	NN	_	_	15	PMOD	_	_
18	,	_	,	_	_	11	P	_	_
19	while	_	IN	_	_	11	VMOD	_	_
20	activation	_	NN	_	_	28	VMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	TBK1/IRF3	_	NN	_	_	21	PMOD	_	_
23	,	_	,	_	_	22	P	_	_
24	ERK1/2	_	NN	_	_	22	COORD	_	_
25	,	_	,	_	_	24	P	_	_
26	or	_	CC	_	_	24	COORD	_	_
27	p38	_	NN	_	_	26	CONJ	_	_
28	was	_	VBD	_	_	19	SUB	_	_
29	not	_	RB	_	_	28	VMOD	_	_
30	,	_	,	_	_	11	P	_	_
31	indicating	_	VBG	_	_	11	VMOD	_	_
32	that	_	IN	_	_	31	VMOD	_	_
33	disrupted	_	VBN	_	_	35	NMOD	_	_
34	NF-kappaB	_	NN	_	_	35	NMOD	_	_
35	signaling	_	NN	_	_	39	VMOD	_	_
36	in	_	IN	_	_	35	NMOD	_	_
37	cpdm	_	NN	_	_	38	NMOD	_	_
38	DC	_	NNS	_	_	36	PMOD	_	_
39	is	_	VBZ	_	_	32	SUB	_	_
40	responsible	_	JJ	_	_	39	VMOD	_	_
41	for	_	IN	_	_	40	AMOD	_	_
42	the	_	DT	_	_	45	NMOD	_	_
43	defective	_	JJ	_	_	45	NMOD	_	_
44	cytokine	_	NN	_	_	45	NMOD	_	_
45	expression	_	NN	_	_	41	PMOD	_	_
46	.	_	.	_	_	3	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	seem	_	VBP	_	_	0	ROOT	_	_
4	to	_	TO	_	_	3	VMOD	_	_
5	contradict	_	VBP	_	_	4	IM	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	recent	_	JJ	_	_	8	NMOD	_	_
8	study	_	NN	_	_	5	VMOD	_	_
9	that	_	WDT	_	_	10	VMOD	_	_
10	found	_	VBD	_	_	8	NMOD	_	_
11	increased	_	VBN	_	_	12	NMOD	_	_
12	levels	_	NNS	_	_	10	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	NF-kappaB	_	NN	_	_	15	NMOD	_	_
15	activation	_	NN	_	_	13	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	IL1	_	NN	_	_	18	NMOD	_	_
18	transcription	_	NN	_	_	16	CONJ	_	_
19	in	_	IN	_	_	10	VMOD	_	_
20	cpdm	_	NN	_	_	21	NMOD	_	_
21	mice	_	NNS	_	_	19	PMOD	_	_
22	[	_	(	_	_	23	P	_	_
23	43	_	CD	_	_	21	PRN	_	_
24	]	_	)	_	_	23	P	_	_
25	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	difference	_	NN	_	_	3	VMOD	_	_
3	can	_	MD	_	_	0	ROOT	_	_
4	probably	_	RB	_	_	3	VMOD	_	_
5	be	_	VB	_	_	3	VC	_	_
6	attributed	_	VBN	_	_	5	VC	_	_
7	to	_	TO	_	_	6	VMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	different	_	JJ	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	7	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	tissues	_	NNS	_	_	11	CONJ	_	_
13	used	_	VBN	_	_	10	APPO	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	these	_	DT	_	_	16	NMOD	_	_
16	studies	_	NNS	_	_	14	PMOD	_	_
17	,	_	,	_	_	3	P	_	_
18	and	_	CC	_	_	3	COORD	_	_
19	may	_	MD	_	_	18	CONJ	_	_
20	point	_	VBP	_	_	19	VC	_	_
21	to	_	TO	_	_	20	VMOD	_	_
22	cell-	_	JJ	_	_	27	NMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	tissue-	_	NN	_	_	25	AMOD	_	_
25	type	_	NN	_	_	23	CONJ	_	_
26	specific	_	JJ	_	_	25	AMOD	_	_
27	functions	_	NNS	_	_	21	PMOD	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	SHARPIN	_	NN	_	_	28	PMOD	_	_
30	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	consistent	_	JJ	_	_	2	VMOD	_	_
4	with	_	IN	_	_	3	AMOD	_	_
5	recent	_	JJ	_	_	6	NMOD	_	_
6	reports	_	NNS	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	tissue-specific	_	JJ	_	_	9	NMOD	_	_
9	effects	_	NNS	_	_	7	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	NF-kappaB	_	NN	_	_	12	NMOD	_	_
12	signaling	_	NN	_	_	10	PMOD	_	_
13	[	_	(	_	_	14	P	_	_
14	44	_	CD	_	_	2	PRN	_	_
15	]	_	)	_	_	14	P	_	_
16	.	_	.	_	_	2	P	_	_
		
1	Ubiquitous	_	JJ	_	_	2	NMOD	_	_
2	activation	_	NN	_	_	16	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	3	PMOD	_	_
5	by	_	IN	_	_	2	NMOD	_	_
6	removing	_	VBG	_	_	7	NMOD	_	_
7	inhibitors	_	NNS	_	_	5	PMOD	_	_
8	such	_	JJ	_	_	9	DEP	_	_
9	as	_	IN	_	_	7	NMOD	_	_
10	A20	_	NN	_	_	9	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	ITCH	_	NN	_	_	11	CONJ	_	_
13	through	_	IN	_	_	2	NMOD	_	_
14	genetic	_	JJ	_	_	15	NMOD	_	_
15	manipulation	_	NN	_	_	13	PMOD	_	_
16	results	_	VBZ	_	_	0	ROOT	_	_
17	in	_	IN	_	_	16	VMOD	_	_
18	widespread	_	JJ	_	_	19	NMOD	_	_
19	inflammation	_	NN	_	_	17	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	consistent	_	JJ	_	_	19	APPO	_	_
22	with	_	IN	_	_	21	AMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	role	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	NF-kappaB	_	NN	_	_	25	PMOD	_	_
27	in	_	IN	_	_	24	NMOD	_	_
28	the	_	DT	_	_	29	NMOD	_	_
29	production	_	NN	_	_	27	PMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	pro-inflammatory	_	JJ	_	_	32	NMOD	_	_
32	mediators	_	NNS	_	_	30	PMOD	_	_
33	[	_	(	_	_	29	P	_	_
34	45	_	CD	_	_	29	NMOD	_	_
35	]	_	)	_	_	29	P	_	_
36	,	_	,	_	_	19	P	_	_
37	[	_	(	_	_	38	P	_	_
38	46	_	CD	_	_	16	PRN	_	_
39	]	_	)	_	_	38	P	_	_
40	.	_	.	_	_	16	P	_	_
		
1	However	_	RB	_	_	19	VMOD	_	_
2	,	_	,	_	_	19	P	_	_
3	selective	_	JJ	_	_	4	NMOD	_	_
4	inhibition	_	NN	_	_	19	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	NF-kappaB	_	NN	_	_	7	NMOD	_	_
7	activation	_	NN	_	_	5	PMOD	_	_
8	in	_	IN	_	_	4	NMOD	_	_
9	parenchymal	_	JJ	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	skin	_	NN	_	_	11	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	liver	_	NN	_	_	13	COORD	_	_
16	,	_	,	_	_	15	P	_	_
17	and	_	CC	_	_	15	COORD	_	_
18	intestine	_	NN	_	_	17	CONJ	_	_
19	results	_	VBZ	_	_	0	ROOT	_	_
20	in	_	IN	_	_	19	VMOD	_	_
21	chronic	_	JJ	_	_	22	NMOD	_	_
22	inflammation	_	NN	_	_	20	PMOD	_	_
23	driven	_	VBN	_	_	22	APPO	_	_
24	by	_	IN	_	_	23	VMOD	_	_
25	NF-kappaB	_	NN	_	_	31	NMOD	_	_
26	competent	_	JJ	_	_	31	NMOD	_	_
27	leukocytes	_	NNS	_	_	31	NMOD	_	_
28	[	_	(	_	_	31	P	_	_
29	47	_	CD	_	_	31	NMOD	_	_
30	]	_	)	_	_	31	P	_	_
31	-[50]	_	NN	_	_	24	PMOD	_	_
32	.	_	.	_	_	19	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	indicates	_	VBZ	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	a	_	DT	_	_	5	NMOD	_	_
5	balance	_	NN	_	_	21	VMOD	_	_
6	between	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	pro-inflammatory	_	JJ	_	_	9	NMOD	_	_
9	role	_	NN	_	_	6	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	NF-kappaB	_	NN	_	_	10	PMOD	_	_
12	in	_	IN	_	_	9	NMOD	_	_
13	leukocytes	_	NNS	_	_	12	PMOD	_	_
14	and	_	CC	_	_	9	COORD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	anti-inflammatory	_	JJ	_	_	17	NMOD	_	_
17	role	_	NN	_	_	14	CONJ	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	parenchymal	_	JJ	_	_	20	NMOD	_	_
20	cells	_	NNS	_	_	18	PMOD	_	_
21	is	_	VBZ	_	_	3	SUB	_	_
22	critical	_	JJ	_	_	21	VMOD	_	_
23	in	_	IN	_	_	22	AMOD	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	maintenance	_	NN	_	_	23	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	tissue	_	NN	_	_	28	NMOD	_	_
28	homeostasis	_	NN	_	_	26	PMOD	_	_
29	.	_	.	_	_	2	P	_	_
		
1	Experiments	_	NNS	_	_	16	VMOD	_	_
2	with	_	IN	_	_	1	NMOD	_	_
3	mice	_	NNS	_	_	2	PMOD	_	_
4	with	_	IN	_	_	1	NMOD	_	_
5	cell-	_	JJ	_	_	8	NMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	tissue-specific	_	JJ	_	_	6	CONJ	_	_
8	deletion	_	NN	_	_	4	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	Sharpin	_	NN	_	_	9	PMOD	_	_
11	,	_	,	_	_	1	P	_	_
12	currently	_	RB	_	_	13	PMOD	_	_
13	under	_	IN	_	_	1	NMOD	_	_
14	way	_	NN	_	_	13	PMOD	_	_
15	,	_	,	_	_	1	P	_	_
16	will	_	MD	_	_	0	ROOT	_	_
17	help	_	VB	_	_	16	VC	_	_
18	to	_	TO	_	_	17	VMOD	_	_
19	elucidate	_	VB	_	_	18	IM	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	role	_	NN	_	_	19	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	SHARPIN	_	NN	_	_	22	PMOD	_	_
24	in	_	IN	_	_	21	NMOD	_	_
25	inflammation	_	NN	_	_	24	PMOD	_	_
26	.	_	.	_	_	16	P	_	_
		
1	Despite	_	IN	_	_	13	VMOD	_	_
2	defective	_	JJ	_	_	4	NMOD	_	_
3	NF-kappaB	_	NN	_	_	4	NMOD	_	_
4	activation	_	NN	_	_	1	PMOD	_	_
5	in	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	absence	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Sharpin	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	8	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	there	_	EX	_	_	13	VMOD	_	_
13	was	_	VBD	_	_	0	ROOT	_	_
14	no	_	DT	_	_	16	NMOD	_	_
15	significant	_	JJ	_	_	16	NMOD	_	_
16	change	_	NN	_	_	13	VMOD	_	_
17	in	_	IN	_	_	13	VMOD	_	_
18	splenic	_	JJ	_	_	20	NMOD	_	_
19	DC	_	NN	_	_	20	NMOD	_	_
20	populations	_	NNS	_	_	17	PMOD	_	_
21	or	_	CC	_	_	20	COORD	_	_
22	expression	_	NN	_	_	21	CONJ	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	co-stimulatory	_	JJ	_	_	25	NMOD	_	_
25	molecules	_	NNS	_	_	23	PMOD	_	_
26	on	_	IN	_	_	25	NMOD	_	_
27	BMDC	_	NN	_	_	26	PMOD	_	_
28	.	_	.	_	_	13	P	_	_
		
1	Different	_	JJ	_	_	3	NMOD	_	_
2	NF-kappaB	_	NN	_	_	3	NMOD	_	_
3	subunits	_	NNS	_	_	16	VMOD	_	_
4	involved	_	VBN	_	_	3	APPO	_	_
5	in	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	10	NMOD	_	_
7	canonical	_	JJ	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	non-canonical	_	JJ	_	_	8	CONJ	_	_
10	branches	_	NNS	_	_	5	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	NF-kappaB	_	NN	_	_	15	NMOD	_	_
14	signaling	_	NN	_	_	15	NMOD	_	_
15	pathway	_	NN	_	_	11	PMOD	_	_
16	have	_	VBP	_	_	0	ROOT	_	_
17	distinct	_	JJ	_	_	18	NMOD	_	_
18	functions	_	NNS	_	_	16	VMOD	_	_
19	to	_	TO	_	_	16	VMOD	_	_
20	control	_	VB	_	_	19	IM	_	_
21	specific	_	JJ	_	_	22	NMOD	_	_
22	aspects	_	NNS	_	_	20	VMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	DC	_	NN	_	_	25	NMOD	_	_
25	development	_	NN	_	_	23	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	function	_	NN	_	_	26	CONJ	_	_
28	[	_	(	_	_	27	P	_	_
29	51	_	CD	_	_	27	NMOD	_	_
30	]	_	)	_	_	27	P	_	_
31	,	_	,	_	_	25	P	_	_
32	[	_	(	_	_	22	P	_	_
33	52	_	CD	_	_	22	NMOD	_	_
34	]	_	)	_	_	22	P	_	_
35	.	_	.	_	_	16	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	non-canonical	_	JJ	_	_	3	NMOD	_	_
3	pathway	_	NN	_	_	11	VMOD	_	_
4	(	_	(	_	_	6	P	_	_
5	p100	_	NN	_	_	6	NMOD	_	_
6	processing	_	NN	_	_	3	PRN	_	_
7	to	_	TO	_	_	6	NMOD	_	_
8	produce	_	VB	_	_	7	IM	_	_
9	p52	_	NN	_	_	8	VMOD	_	_
10	)	_	)	_	_	6	P	_	_
11	appears	_	VBZ	_	_	0	ROOT	_	_
12	to	_	TO	_	_	11	VMOD	_	_
13	be	_	VB	_	_	12	IM	_	_
14	intact	_	JJ	_	_	13	VMOD	_	_
15	in	_	IN	_	_	14	AMOD	_	_
16	SHARPIN-deficient	_	JJ	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	15	PMOD	_	_
18	[	_	(	_	_	19	P	_	_
19	7	_	CD	_	_	17	PRN	_	_
20	]	_	)	_	_	19	P	_	_
21	,	_	,	_	_	11	P	_	_
22	[	_	(	_	_	23	P	_	_
23	9	_	CD	_	_	25	PRN	_	_
24	]	_	)	_	_	23	P	_	_
25	suggesting	_	VBG	_	_	11	VMOD	_	_
26	that	_	IN	_	_	25	VMOD	_	_
27	the	_	DT	_	_	30	NMOD	_	_
28	NF-kappaB	_	NN	_	_	30	NMOD	_	_
29	heterodimer	_	NN	_	_	30	NMOD	_	_
30	p52/RELB	_	NN	_	_	31	VMOD	_	_
31	is	_	VBZ	_	_	26	SUB	_	_
32	sufficient	_	JJ	_	_	31	VMOD	_	_
33	to	_	TO	_	_	32	AMOD	_	_
34	maintain	_	VB	_	_	33	IM	_	_
35	the	_	DT	_	_	37	NMOD	_	_
36	normal	_	JJ	_	_	37	NMOD	_	_
37	regulation	_	NN	_	_	34	VMOD	_	_
38	of	_	IN	_	_	37	NMOD	_	_
39	DC	_	NN	_	_	40	NMOD	_	_
40	homeostasis	_	NN	_	_	38	PMOD	_	_
41	and	_	CC	_	_	40	COORD	_	_
42	maturation	_	NN	_	_	41	CONJ	_	_
43	.	_	.	_	_	11	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	molecular	_	JJ	_	_	3	NMOD	_	_
3	basis	_	NN	_	_	15	VMOD	_	_
4	by	_	IN	_	_	9	VMOD	_	_
5	which	_	WDT	_	_	4	PMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	Sharpin	_	NN	_	_	8	NMOD	_	_
8	mutation	_	NN	_	_	9	VMOD	_	_
9	causes	_	VBZ	_	_	3	NMOD	_	_
10	reduced	_	VBN	_	_	12	NMOD	_	_
11	NF-kappaB	_	NN	_	_	12	NMOD	_	_
12	activation	_	NN	_	_	9	VMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	BMDC	_	NNS	_	_	13	PMOD	_	_
15	remains	_	VBZ	_	_	0	ROOT	_	_
16	to	_	TO	_	_	15	VMOD	_	_
17	be	_	VB	_	_	16	IM	_	_
18	determined	_	VBN	_	_	17	VC	_	_
19	.	_	.	_	_	15	P	_	_
		
1	LPS	_	NN	_	_	7	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	poly	_	NN	_	_	4	NMOD	_	_
4	I:C	_	NN	_	_	2	CONJ	_	_
5	used	_	VBN	_	_	1	APPO	_	_
6	here	_	RB	_	_	5	VMOD	_	_
7	are	_	VBP	_	_	0	ROOT	_	_
8	well-defined	_	JJ	_	_	9	NMOD	_	_
9	ligands	_	NNS	_	_	7	VMOD	_	_
10	that	_	WDT	_	_	12	VMOD	_	_
11	specifically	_	RB	_	_	12	VMOD	_	_
12	engage	_	VB	_	_	9	NMOD	_	_
13	TLR4	_	NN	_	_	12	VMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	TLR3	_	NN	_	_	14	CONJ	_	_
16	,	_	,	_	_	12	P	_	_
17	respectively	_	RB	_	_	12	VMOD	_	_
18	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	expression	_	NN	_	_	3	NMOD	_	_
3	profile	_	NN	_	_	8	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	surface	_	NN	_	_	7	NMOD	_	_
6	TLR4	_	NN	_	_	7	NMOD	_	_
7	complexes	_	NNS	_	_	4	PMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	similar	_	JJ	_	_	8	VMOD	_	_
10	between	_	IN	_	_	9	AMOD	_	_
11	WT	_	NN	_	_	10	PMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	cpdm	_	NN	_	_	12	CONJ	_	_
14	BMDC	_	NNS	_	_	13	COORD	_	_
15	suggesting	_	VBG	_	_	8	VC	_	_
16	that	_	IN	_	_	15	VMOD	_	_
17	defective	_	JJ	_	_	19	NMOD	_	_
18	NF-kappaB	_	NN	_	_	19	NMOD	_	_
19	activation	_	NN	_	_	20	VMOD	_	_
20	is	_	VBZ	_	_	16	SUB	_	_
21	not	_	RB	_	_	20	VMOD	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	result	_	NN	_	_	20	VMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	differential	_	JJ	_	_	27	NMOD	_	_
26	TLR	_	NN	_	_	27	NMOD	_	_
27	expression	_	NN	_	_	24	PMOD	_	_
28	on	_	IN	_	_	27	NMOD	_	_
29	target	_	NN	_	_	30	NMOD	_	_
30	cells	_	NNS	_	_	28	PMOD	_	_
31	.	_	.	_	_	8	P	_	_
		
1	LPS	_	NN	_	_	2	VMOD	_	_
2	engages	_	VBZ	_	_	0	ROOT	_	_
3	TLR4	_	NN	_	_	2	VMOD	_	_
4	to	_	TO	_	_	2	VMOD	_	_
5	activate	_	VB	_	_	4	IM	_	_
6	MYD88-dependent	_	JJ	_	_	9	NMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	TRIF-dependent	_	JJ	_	_	7	CONJ	_	_
9	pathways	_	NNS	_	_	5	VMOD	_	_
10	,	_	,	_	_	2	P	_	_
11	whereas	_	IN	_	_	2	VMOD	_	_
12	TLR3	_	NN	_	_	18	VMOD	_	_
13	stimulated	_	VBN	_	_	12	APPO	_	_
14	by	_	IN	_	_	13	VMOD	_	_
15	poly	_	NN	_	_	16	NMOD	_	_
16	I:C	_	NN	_	_	14	PMOD	_	_
17	only	_	RB	_	_	18	VMOD	_	_
18	triggers	_	VBZ	_	_	11	SUB	_	_
19	TRIF-dependent	_	JJ	_	_	20	NMOD	_	_
20	signaling	_	NN	_	_	18	VMOD	_	_
21	[	_	(	_	_	22	P	_	_
22	53	_	CD	_	_	18	PRN	_	_
23	]	_	)	_	_	22	P	_	_
24	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	defective	_	JJ	_	_	4	NMOD	_	_
3	NF-kappaB	_	NN	_	_	4	NMOD	_	_
4	activation	_	NN	_	_	8	VMOD	_	_
5	by	_	IN	_	_	4	NMOD	_	_
6	both	_	DT	_	_	7	NMOD	_	_
7	stimuli	_	NNS	_	_	5	PMOD	_	_
8	suggests	_	VBZ	_	_	0	ROOT	_	_
9	that	_	IN	_	_	8	VMOD	_	_
10	the	_	DT	_	_	12	NMOD	_	_
11	Sharpin	_	NN	_	_	12	NMOD	_	_
12	mutation	_	NN	_	_	13	VMOD	_	_
13	interferes	_	VBZ	_	_	9	SUB	_	_
14	with	_	IN	_	_	13	VMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	protein	_	NN	_	_	17	NMOD	_	_
17	adaptors	_	NNS	_	_	14	PMOD	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	kinases	_	NNS	_	_	18	CONJ	_	_
20	shared	_	VBN	_	_	17	APPO	_	_
21	by	_	IN	_	_	20	VMOD	_	_
22	both	_	DT	_	_	24	NMOD	_	_
23	signaling	_	NN	_	_	24	NMOD	_	_
24	pathways	_	NNS	_	_	21	PMOD	_	_
25	,	_	,	_	_	17	P	_	_
26	such	_	JJ	_	_	27	DEP	_	_
27	as	_	IN	_	_	17	NMOD	_	_
28	RIP1	_	NN	_	_	27	PMOD	_	_
29	and	_	CC	_	_	28	COORD	_	_
30	TRAF6	_	NN	_	_	29	CONJ	_	_
31	[	_	(	_	_	30	P	_	_
32	18	_	CD	_	_	30	NMOD	_	_
33	]	_	)	_	_	30	P	_	_
34	.	_	.	_	_	8	P	_	_
		
1	Recent	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	demonstrated	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	SHARPIN	_	NN	_	_	6	VMOD	_	_
6	interacts	_	VBZ	_	_	4	SUB	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	HOIP	_	NN	_	_	7	PMOD	_	_
9	to	_	TO	_	_	6	VMOD	_	_
10	form	_	VB	_	_	9	IM	_	_
11	LUBAC	_	NN	_	_	10	VMOD	_	_
12	that	_	WDT	_	_	13	VMOD	_	_
13	exerts	_	VBZ	_	_	11	NMOD	_	_
14	its	_	PRP$	_	_	16	NMOD	_	_
15	linear-ubiquitin-chain-ligase	_	JJ	_	_	16	NMOD	_	_
16	activity	_	NN	_	_	13	VMOD	_	_
17	on	_	IN	_	_	13	VMOD	_	_
18	NF-kappaB	_	NN	_	_	20	NMOD	_	_
19	signaling	_	NN	_	_	20	NMOD	_	_
20	players	_	NNS	_	_	17	PMOD	_	_
21	RIP1	_	NN	_	_	20	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	NEMO	_	NN	_	_	22	CONJ	_	_
24	[	_	(	_	_	23	P	_	_
25	7	_	CD	_	_	23	NMOD	_	_
26	]	_	)	_	_	23	P	_	_
27	,	_	,	_	_	20	P	_	_
28	an	_	DT	_	_	30	NMOD	_	_
29	essential	_	JJ	_	_	30	NMOD	_	_
30	step	_	NN	_	_	20	APPO	_	_
31	for	_	IN	_	_	30	NMOD	_	_
32	intact	_	JJ	_	_	35	NMOD	_	_
33	TNFalpha-stimulated	_	JJ	_	_	35	NMOD	_	_
34	NF-kappaB	_	NN	_	_	35	NMOD	_	_
35	activation	_	NN	_	_	31	PMOD	_	_
36	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	Sharpin	_	NN	_	_	4	NMOD	_	_
3	null	_	NN	_	_	4	NMOD	_	_
4	mutation	_	NN	_	_	5	VMOD	_	_
5	disrupts	_	VBZ	_	_	0	ROOT	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	ubiquitylation	_	NN	_	_	8	NMOD	_	_
8	process	_	NN	_	_	5	VMOD	_	_
9	and	_	CC	_	_	5	COORD	_	_
10	abrogates	_	VBZ	_	_	9	CONJ	_	_
11	the	_	DT	_	_	15	NMOD	_	_
12	TNFalpha-induced	_	JJ	_	_	15	NMOD	_	_
13	NF-kappaB	_	NN	_	_	15	NMOD	_	_
14	signaling	_	NN	_	_	15	NMOD	_	_
15	pathway	_	NN	_	_	10	VMOD	_	_
16	.	_	.	_	_	5	P	_	_
		
1	Since	_	IN	_	_	16	VMOD	_	_
2	TNFR	_	NN	_	_	6	VMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	TLR	_	NN	_	_	3	CONJ	_	_
5	partially	_	RB	_	_	6	VMOD	_	_
6	share	_	VBP	_	_	1	SUB	_	_
7	their	_	PRP$	_	_	10	NMOD	_	_
8	downstream	_	JJ	_	_	10	NMOD	_	_
9	signaling	_	NN	_	_	10	NMOD	_	_
10	cascades	_	NNS	_	_	6	VMOD	_	_
11	,	_	,	_	_	16	P	_	_
12	a	_	DT	_	_	15	NMOD	_	_
13	similar	_	JJ	_	_	15	NMOD	_	_
14	ubiquitin-mediated	_	JJ	_	_	15	NMOD	_	_
15	regulation	_	NN	_	_	16	VMOD	_	_
16	may	_	MD	_	_	0	ROOT	_	_
17	hold	_	VB	_	_	16	VC	_	_
18	true	_	JJ	_	_	17	VMOD	_	_
19	for	_	IN	_	_	18	AMOD	_	_
20	SHARPIN	_	NN	_	_	19	PMOD	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	LPS-	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	poly	_	NN	_	_	27	NMOD	_	_
25	I:C-induced	_	JJ	_	_	27	NMOD	_	_
26	NF-kappaB	_	NN	_	_	27	NMOD	_	_
27	activation	_	NN	_	_	23	CONJ	_	_
28	.	_	.	_	_	16	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	summary	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	7	P	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	present	_	JJ	_	_	6	NMOD	_	_
6	study	_	NN	_	_	7	VMOD	_	_
7	identified	_	VBD	_	_	0	ROOT	_	_
8	an	_	DT	_	_	10	NMOD	_	_
9	indispensible	_	JJ	_	_	10	NMOD	_	_
10	role	_	NN	_	_	7	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	SHARPIN	_	NN	_	_	11	PMOD	_	_
13	in	_	IN	_	_	10	NMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	production	_	NN	_	_	13	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	pro-inflammatory	_	JJ	_	_	18	NMOD	_	_
18	mediators	_	NNS	_	_	16	PMOD	_	_
19	and	_	CC	_	_	10	COORD	_	_
20	TLR-induced	_	JJ	_	_	22	NMOD	_	_
21	NF-kappaB	_	NN	_	_	22	NMOD	_	_
22	signaling	_	NN	_	_	19	CONJ	_	_
23	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	impaired	_	JJ	_	_	4	NMOD	_	_
3	Th1-stimulating	_	NN	_	_	4	NMOD	_	_
4	ability	_	NN	_	_	8	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	Sharpin-deficient	_	JJ	_	_	7	NMOD	_	_
7	DC	_	NNS	_	_	5	PMOD	_	_
8	may	_	MD	_	_	0	ROOT	_	_
9	account	_	VB	_	_	8	VC	_	_
10	for	_	IN	_	_	9	VMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	Th2-dominant	_	JJ	_	_	14	NMOD	_	_
13	inflammatory	_	JJ	_	_	14	NMOD	_	_
14	phenotype	_	NN	_	_	10	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	cpdm	_	NN	_	_	17	NMOD	_	_
17	mice	_	NNS	_	_	15	PMOD	_	_
18	.	_	.	_	_	8	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	balance	_	NN	_	_	8	VMOD	_	_
3	between	_	IN	_	_	2	NMOD	_	_
4	Th1	_	NN	_	_	3	PMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	Th2	_	NN	_	_	5	CONJ	_	_
7	differentiation	_	NN	_	_	6	COORD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	critical	_	JJ	_	_	8	VMOD	_	_
10	for	_	IN	_	_	9	AMOD	_	_
11	immune	_	JJ	_	_	12	NMOD	_	_
12	homeostasis	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	8	P	_	_
		
1	A	_	DT	_	_	3	NMOD	_	_
2	better	_	JJR	_	_	3	NMOD	_	_
3	understanding	_	NN	_	_	10	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	how	_	WRB	_	_	8	VMOD	_	_
6	such	_	JJ	_	_	7	NMOD	_	_
7	balance	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	4	PMOD	_	_
9	maintained	_	VBN	_	_	8	VC	_	_
10	will	_	MD	_	_	0	ROOT	_	_
11	help	_	VB	_	_	10	VC	_	_
12	design	_	NN	_	_	14	NMOD	_	_
13	cytokine	_	NN	_	_	14	NMOD	_	_
14	treatment	_	NN	_	_	11	VMOD	_	_
15	for	_	IN	_	_	14	NMOD	_	_
16	human	_	JJ	_	_	17	NMOD	_	_
17	diseases	_	NNS	_	_	15	PMOD	_	_
18	with	_	IN	_	_	17	NMOD	_	_
19	Th2-biased	_	JJ	_	_	21	NMOD	_	_
20	cytokine	_	NN	_	_	21	NMOD	_	_
21	secretion	_	NN	_	_	18	PMOD	_	_
22	similar	_	JJ	_	_	21	APPO	_	_
23	to	_	TO	_	_	22	AMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	mouse	_	NN	_	_	26	NMOD	_	_
26	cpdm	_	NN	_	_	23	PMOD	_	_
27	,	_	,	_	_	17	P	_	_
28	such	_	JJ	_	_	29	DEP	_	_
29	as	_	IN	_	_	17	NMOD	_	_
30	allergies	_	NNS	_	_	29	PMOD	_	_
31	and	_	CC	_	_	30	COORD	_	_
32	hypereosinophilic	_	JJ	_	_	33	NMOD	_	_
33	syndromes	_	NNS	_	_	31	CONJ	_	_
34	.	_	.	_	_	10	P	_	_
		
